Let’s explore “persistent inflammation”

This report overview covers rs2857261, rs1057972, natural killer cells, CD8+ T cells, and the report’s interpretation of high-expression variants.

This report overview covers interleukin-1 beta, NLRP3, inflammasome activation, caspase-1, inflammatory conditions, and the treatment comparisons in the source.

This report overview covers NASH, liver cirrhosis, oxidative stress, and the treatment comparisons presented in the source report.

This report overview covers rs2236225, rs1076991, folate-dependent one-carbon metabolism, nucleotide synthesis, homocysteine, and the report’s discussion of double homozygosity.

This report overview covers SERPINE1 / PAI-1, rs1799889, 4G/5G, fibrinolysis, hyperhomocysteinemia (HHcy), vascular health, and the report’s comparisons of approaches to clotting risk.

This report overview covers tumor necrosis factor-alpha, TNFR1, TNFR2, rs1800629, inflammatory signaling, and treatment comparisons in the source reports.

Dr. Purser’s subscriber report on PAI-1 4G/5G, homocysteine, and brain infarct risk. Read the report on Substack.

Dr. Purser’s subscriber report on IL-5, cytokine genetics, and the topics discussed in his homozygous IL5 variant report.

Dr. Purser explores questions about primary ovarian insufficiency (POI) and cytokines. The full subscriber post is on Substack.

Dan and Jackson discuss the Algevity ingredient, Nrf2, antioxidant research, and VARS Catalase, including an update on the study’s publication status.

This report overview covers eotaxin-1, CCR3, eosinophils, allergy, and the report’s discussion of respiratory and neurological conditions.

This report overview covers MCP-4, CCR1, CCR2, CCR3, immune-cell recruitment, asthma, allergic rhinitis, and rheumatoid arthritis.